Phase I, Study in Chinese NSCLC Patients

Clinical trial NCT02529995 · COMPLETED

Trial details

NCT number: NCT02529995
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive

Start date: 2015-08-24
Primary completion: 2016-01-28
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.